Erin E. Burkhart - 16 May 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
GVP, Chief Accounting Officer
Signature
/s/ Laura Randall Woodhead, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
16 May 2022
Net transactions value
$0
Form type
4
Filing time
18 May 2022, 20:42:05 UTC
Previous filing
11 May 2022
Next filing
17 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $0 +11,130 $0.000000 11,130 16 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Award $0 +17,490 $0.000000 17,490 16 May 2022 Common Stock 17,490 $77.32 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on May 16, 2022. Price not applicable.
F2 Option grant vests 12/48th on May 16, 2023 and 1/48th on the 16th day of each month thereafter.